30/09/201421/10/2023 Helix Reports On Interim Review Of The Polish L-DOS47 Monotherapy Study In Non-Small Cell Lung Cancer admin 0 Comments
26/09/201421/10/2023 Helix BioPharma Corp. Initiates Enrollment For Tenth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 admin 0 Comments
25/09/201421/10/2023 Helix BioPharma Corp. To Present At The 2nd Global Life Sciences Conference In Warsaw, Poland admin 0 Comments